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The study aimed to evaluate the suitability of myeloperoxidase (MPO) content as a local indicator of chronic inﬂammation,
using the periodontal disease model. Anesthetized adult male Holtzman rats had their second left maxilar molar tied by a thread
for 11 days and were then killed. Blood samples and photographic images from histopathological inﬂamed and noninﬂamed
(contralateral) neighboring gingivomucosal specimens were collected for cell counts and MPO level analysis. Diseased animals
were also treated with pharmacological tools such as the anti-inﬂammatory drug celecoxib or the opioid morphine. Increased
blood neutrophils and local cell numbers characterized diseased animals. However, local MPO content was increased in inﬂamed
and noninﬂamed tissues from diseased animals. Celecoxib and morphine reduced blood neutrophils and bilateral MPO content,
but only celecoxib reduced local cell numbers in diseased animals. It is concluded that MPO content is a good indicator of a
systemic rather than a local inﬂammation in a chronic inﬂammatory condition.
Copyright © 2009 Celso Martins Queiroz-Junior et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Migration and accumulation of cells such as polymor-
phonuclear leukocytes (PMNs) in tissues is considered a
characteristic feature of the host response to injuries [1, 2].
Locally, PMNs neutrophils release antimicrobial and inﬂam-
matory mediators, which act synergistically to protect and
maintain tissues free of pathogens [3, 4]. Myeloperoxidase
(MPO), one of such active substances, is a constituent of the
azurophilic granules of PMNs that oxidizes chloride ions to
the potent bactericidal oxidant hypochlorous acid (HOCl)
[5]. MPO secretion by stimulated neutrophils acts, thus, as
ah o s td e f e n s em e c h a n i s mb ye ﬃciently mediating microbial
killing.Duetoitsimportanceduringinﬂammatoryprocesses
and for being an indicator of PMN presence in tissues, MPO
has been widely used as an inﬂammatory marker of both
acute and chronic conditions [6]. Moreover, MPO changes
have also been associated to the severity of many diseases
[5, 7, 8].
We have previously shown, using an experimental model
of periodontal disease [9], a high increase in cell numbers
present in gingival tissues as compared with controls,
which was taken as an indicator of local inﬂammation
[10–12]. However, characterization of speciﬁc cell lines
in such inﬂamed tissues was not accomplished in those
studies, given the diﬃculties to assess individually each
cell type. The present study aimed to assess whether PMN
neutrophils accounted for the cell inﬂux by means of
the local MPO content in inﬂamed and non-inﬂamed
gingival tissues. Additional animal groups treated with
celecoxib and morphine were also evaluated for local MPO
content since such drugs have been shown to reduce2 Mediators of Inﬂammation
inﬂammatory signs detected in this experimental model
[11, 12].
2.MaterialsandMethods
2.1. The Periodontal Disease Model. In this study we used
a standard model of periodontal disease in rats [9], which
has been shown to be adjusted to our conditions [11,
12]. In brief, male Holtzman rats (250–300g) were anaes-
thetizedwithamixtureofketamine-xylazine(116–23mg/kg,
resp.) given by intramuscular (i.m.) route in a volume of
0.1mL/100g. A sterile silk ligature was tied around the
cervix of the second left maxillary molar tooth, serving
as a retention device for subgingival oral microorganisms.
This was considered the ipsilateral side. The contralateral
side was used as the non-inﬂamed control. Naive rats were
left nonligated. All the animals were killed (using a CO2
chamber) on the 11th day of tooth ligation. The handling
of the animals was approved by the University Animal Ethics
Committee.
2.2. Photographic Records. Photographies from control
(nonligated) and experimental (ligated) periodontal tissues
were obtained at 15-fold magniﬁcation through a digital still
camera (Sony Cyber-Shot 7.2 megapixels, Sony Electronics
Inc., San Diego, CA, USA) adapted to a stereoscopic
loupe (ZP101, Prior Scientiﬁc Instruments Ltd., Fisher
Scientiﬁc, Pittsburgh, PA, USA) in order to show macro-
scopic diﬀerences between non-inﬂamed and inﬂamed
sites.
2.3. Determination of Myeloperoxidase (MPO) Activity. Fol-
lowing standard methods [13, 14], the MPO activity was
assessed as a quantitative measure to quantify the extent of
neutrophil accumulation in whole tissue samples. Gingivo-
mucosaltissue(∼20mm2)surroundingthemaxillarysecond
molar tooth was removed from ipsi and contralateral sides
of the same animals in all groups. After removing, tissue
samples were weighed, homogenized in 2mL cooled (4◦C)
phosphate buﬀer (0.1M NaCl, 0.02M Na3PO4, 0.015M
NaEDTA, pH4.7), and centrifuged at 4◦Cf o r2 0 m i n u t e s
at 12.000rotations per minute (r.p.m.). Pellets were resus-
pended in 2mL 0.05M sodium phosphate buﬀer (pH5.4)
containing0.5%hexa-1,6-bisdecyltrimethylammoniumbro-
mide (HTAB, Sigma Chemical Co., USA). The suspensions
were freeze thawed three times and ﬁnally centrifuged at
10.000r.p.m. for 10minutes at 4◦C. MPO activity in the
resulting supernatant was assayed by mixing 25μLo f3 , 3  -
5,5 -tetramethylbenzidine(TMB,SigmaChemicalCo.,USA)
prepared in dimethylsulfoxide (DMSO, Merck, USA), in
a ﬁnal concentration of 1.6mM, with addition of 100μL
H2O2 dissolved in phosphate buﬀer (pH 5.4) containing
0.5% HTAB, in a ﬁnal concentration of 0.003% (v/v), and
25μL of the supernatant from the processed tissue sample.
The assay was carried out in a 96-well microplate and was
started by adding H2O2 to the supernatant sample and TMB
solution, and incubated for 5minutes at 37
◦C. The reaction
was terminated by adding 100μL4MH 2SO4 at 4◦ Ca n dw a s
quantiﬁedcolorimetricallyat450nminaspectrophotometer
(SPECTRAmax PLUS-Molecular Devices). MPO assay was
a l s op e r f o r m e di ns a m p l e sc o l l e c t e df r o man a i v eg r o u p
(nonligated, nontreated rats, n = 6). Results were expressed
as change in optical density (OD) per gram (g) of wet
tissue.
2.4. Assessment of Blood Leukocyte Number. On the 11th
day of tooth ligation and under anesthesia, blood samples
(30μL) were collected from femoral vein of control and drug
treated-animals. Counting of whole blood cells (cells/mm3)
used a mixture of 20μL blood samples + 380μLo fT u r k
Blue solution in a Neubauer chamber under a light micro-
scope (200-fold magniﬁcation). For speciﬁc cell counting, a
smear of the animal blood (10μL) stained by Panotic L.B.
(Haematological Dye System; 0.1% v/v, triarylmethane/0.1%
v/v, xanthenes/0.1% v/v, thiazines, Laborclin) was used for
analysis in a light microscope (1000-fold magniﬁcation).
2.5. Assessment of Local (Gingivomucosal) Cells. Specimens
of gingivomucosal tissue from ligated (ipsilateral) and non-
ligated (contralateral) second molar teeth were removed as
described in item 3 above (and) were ﬁxed in 10% buﬀered
formalin solution pH 7.2 during 48 hours. Samples were
washed in tap water for 24 hours, dehydrated in serial
alcohols, cleared, and embedded in paraﬃn. Paraﬃn blocks
were cut in serial 4μm sections. Six images from diﬀerent
locations of the gingival tissue section were obtained at 400-
fold magniﬁcation. An automatic macro recorder assembler
(an algorithm of the KS300 software) was elaborated for
capture, image processing, and segmentation, deﬁnition of
morphometrical conditions and counts of all the nuclei
contained in each image, as previously described [10–
12]. Image processing techniques were applied in order to
highlight the nucleus of the cells. Segmentation permitted
the separation of these nuclei from the cell cytoplasm and
fromotherstructuresinthesection,suchasbloodvesselsand
extracellular space, enabling the creation of a binary image
containing these two locations, nucleus and other spaces.
The nuclei from resident cells in the gingivae as well as
newly recruited leukocytes were then counted. The ﬁgures
so obtained thus represented the total number of cells in
gingivae under each speciﬁed condition. An observer who
was unaware of the tissue sample captured the images and
made the measurements. The result of the six ﬁelds counted
was totaled and represented the total number of cells present
in the tissue sample/animal.
2.6. Drug Administration Protocols. Either celecoxib (12mg/
kg/day; Searle & Co., Puerto Rico; n = 6 rats) or morphine
(1 mg/kg/day; Merk, USA; n = 4 rats) was administered, in
two diﬀerent groups of rats, by subcutaneous (s.c.) bolus
injection into a skin fold in the dorsal region (volume of
0.1 mL per 100g body weight) from the 3rd to the 5th
day of ligation. This protocol for drug treatment has been
previously shown to be eﬀective to relieve the inﬂammatory
signs of periodontal disease under our conditions [11,
12]. A control group was administered with sterile saline,Mediators of Inﬂammation 3
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Figure 1: Photographs from healthy (a) and periodontal-diseased
teeth (b). (a) Nonligated teeth do not show signs of inﬂammation.
The periodontal supporting tissues present a healthy macroscopic
aspect. Some left residues remained on the surface of the normal
tooth. (b) Macroscopic signs of inﬂammation could be observed
next to the second left molar of periodontal-diseased rats, after 11
days of ligation. Signs include redness, swelling, and destruction
of the normal gingivomucosal tissue around the aﬀected tooth
(dark arrows), as well as a furcation lesion (white arrow). Original
magniﬁcation: 15X.
the vehicle of drugs used, by the same route and time of the
drug-treated animals (n = 6 rats).
2.7. Statistical Analysis. The measurements are presented
as mean ± Standard Error of the Mean (SEM) of the
MPO activity (OD/g of wet tissue), number of blood cells
(cells/mm3 and neutrophils/mm3), and number of total
gingival cells (cells/ﬁelds) from 4–6 animals. Diﬀerences
between means were evaluated by one-way ANOVA followed
by the Student-Newman-Keuls test. Probabilities smaller
than 5% (P<.05) were considered statistically signiﬁcant.
3. Results
3.1. Macro- and Microscopic Features of Gingivomucosal
Tissues From Periodontal-Diseased Animals. Panels (a) and
(b) in Figure 1 show photographic recordings from a
healthy (contra-lateral) and an aﬀected (ipsilateral) tooth,
respectively, from rats in which periodontal disease had
been induced 11 days before. The placement of a silk
ligature around the second rat maxillary molar tooth
induced a progressive periodontal disease, as previously
shown [11, 12]. In panel (b), of the same Figure, it can
be observed that the supportive tissues around the inﬂicted
tooth show clear signs of an ongoing-inﬂammatory process,
including redness, increased volume, and destruction of the
Table 1: Leukocyte number in blood collected from untreated
control and treated periodontal-diseased rats.
Group Blood leukocytes (total cells/mm3; Mean ± SEM)
Naive 9,462 ± 352
Control 10,575 ± 1,213
Celecoxib 9,237 ± 936
Morphine 11,612 ± 226
On the 11th day of tooth ligation, naive, drug-treated (celecoxib at
12mg/kg/day and morphine at 1mg/kg/day), and saline treated groups of
animals were anesthetized with 23mg/kg xylazine and 116mg/kg ketamine
hydrochloride, and blood samples were obtained by femoral vein bleeding.
Whole blood cell counting (cells/mm3) was performed using a mixture of
20μL of blood samples + 380 μL of Turk Blue in a Neubauer chamber under
a light microscope (x 200-fold). Celecoxib and morphine were systemically
administered for 3 consecutive days, from 3rd to 5th day after ligature
placement as described in Materials and Methods. Statistical analysis: P>
.05, one-way ANOVA followed by Student-Newman-Keuls test, 4–6 animals
per group.
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Figure 2: Blood neutrophil number in whole blood from na¨ ıve,
control, and treated periodontal-diseased rats. For speciﬁc cell
counting (%), a smear of the blood was prepared and stained by
Panotic L.B. haematological dye system and observed under a light
microscope (1000-fold). Celecoxib (12mg/kg/day) or morphine
(1mg/kg/day) was subcutaneously administered for 3 consecutive
days, from 3rd to 5th day after ligature placement as described in
Materials and Methods. ∗ and # indicate signiﬁcant diﬀerence (P<
.05) in relation to naive and control group, respectively; one-way
ANOVA followed by Student-Newman-Keuls test, 4–6 animals per
group.
normal gingivomucosal structures as compared with the
contralateral tooth from the same animals, shown in panel
(a). Furcation lesion, a characteristic feature of periodontal
destruction in this disease, was also detected, as indicated by
the arrow in panel (b) (Figure 1). In contrast, macroscopic
evaluation of gingivomucosal tissues from naive (not shown)
or contralateral sites indicated a healthy tissue, with no signs
of redness, attachment and/or bone loss (Panel (a), ﬁgure
1). In relation to microscopic changes, and although not
reﬂected in total blood cell numbers obtained (Table 1), the
number of circulating neutrophils in periodontal-diseased
animals was twice (3,887 ± 469; Mean ± SEM) that found
in naive animals (1,897 ± 298; Mean ± SEM; P< .05,
ANOVA followed by Student-Newman-Keuls test), as shown
in Figure 2.4 Mediators of Inﬂammation
3.2. Gingival Cell Number and Myeloperoxidase Activity in
Tissues from Periodontal-Diseased Animals. Morphometric
analysis of gingival tissues surrounding ipsilateral second
molar teeth from periodontal-challenged animals following
11 days of disease showed an approximate 2.5-fold increase
in the total number of local cells (1,705 ± 21; Mean ± SEM;
P<.05, ANOVA followed by Student-Newman-Keuls test)
as compared with their contralateral counterpart (702 ± 66;
Mean ± SEM) controls or naive (658 ± 60; Mean ± SEM)
animals, as shown in panel (a) of Figure 3. Myeloperoxidase
activity in gingival tissues obtained from diseased animals
was shown to be also raised (5.35 ± 0.43; Mean ± SEM;
P<. 05,ANOVAfollowedbyStudent-Newman-Keulstest)in
comparison with naive animals (2.62 ± 0.64; Mean ± SEM),
by more than 2 fold, but surprisingly, in both ipsilateral and
contralateral tissues (panel (c), Figure 3).
3.3. Eﬀects of Celecoxib and Morphine in Periodontal-Diseased
Animals. To assess their impact on MPO measurements,
celecoxib and morphine, two drugs of already demonstrated
eﬃcacy on cell migration were investigated in the periodon-
taldiseasemodel.AsshowninFigure 2,aremarkablespeciﬁc
decrease in circulating neutrophil numbers, which returned
to naive levels, was observed in either celecoxib-(1575 ± 291;
Mean ± SEM) or morphine-(2079 ± 581; Mean ± SEM)
treated groups of animals (P<.05 in relation to controls,
ANOVA followed by Student-Newman-Keuls test).
The morphometric analysis showed, in relation to con-
trol animals, that celecoxib treatment practically reduced to
naive levels the (local) gingival number of cells, whereas
morphine treatment did not (panel (b), Figure 3). Strikingly,
both celecoxib and morphine treatments reduced to naive
levels MPO content in ipsi and contralateral gingival tissues
of periodontal-diseased animals (panel (d), Figure 3).
4. Discussion
Myeloperoxidase activity has been used as a good model
to estimate neutrophil content in inﬂamed tissues [6, 15];
and for this reason, it has been widely used as a biomarker
of inﬂammation. Moreover, myeloperoxidase activity was
alreadyreportedtobeincreasedincrevicularﬂuidofpatients
with infectious periodontal disease [7], and the concen-
tration of this enzyme in periodontal tissues is correlated
with the clinical state of periodontitis [16], which suggests
that this measurement could be a good complement for
diagnosis of such a condition. In fact, our results showed
that, in rats compromised by the experimental periodontal
disease, the myeloperoxidase activity was signiﬁcantly higher
at the sites of the chronic periodontitis, when compared
to that of naive animals. These data are in accordance
with many studies in literature, which have shown higher
levels of myeloperoxidase in sites with periodontitis [16–
18], total myeloperoxidase activity and myeloperoxidase
concentration being present in signiﬁcantly lower levels
in healthy sites than in inﬂicted ones [19]. During peri-
odontal disease development, a remarkable accumulation of
neutrophils recruited from blood vessels can be observed
in compromised periodontal tissues [20, 21]. Moreover,
accumulation of neutrophils is related not only to host
response to bacterial invasion but also to periodontal
tissue destruction itself [20, 22]. Indeed, in the present
study a raise (app. 2-fold increase) in blood neutrophils
was observed in diseased animals along with a raise in
local MPO content, but intriguingly, in both inﬂamed and
noninﬂamed tissues from the diseased animals. It is our
working hypothesis that all the specimens used for MPO
determinations, from both the inﬂicted and noninﬂicted
toothneighboringgingivaltissues,containedinﬂamedblood
vessels full of circulating neutrophils, which accounted for
a MPO positive response shown by periodontal-diseased
animals. The intriguing issue was that histological evaluation
of the gingivomucosal tissues surrounding rat teeth with
evident signs of periodontal disease was also accompanied
by a huge local content of cells, a ﬁnding not observed in
tissues surrounding the contralateral teeth, which was in
accordance with previous publications of our group [11, 12].
Therefore, local high myeloperoxidase content presented
here did not correlate either with histological ﬁndings or
with the objective macroscopic evaluation of nonchallenged
tissues, clearly suggesting that the MPO model alone is not a
good marker of local inﬂammation in an established chronic
inﬂammation. Rather, it is a good marker of a systemic
inﬂammation in this chronic inﬂammatory condition.
Likewise, it could be expected that systemic treatment
using drugs of established mechanisms of action, such
as celecoxib and morphine, a selective nonsteroidal anti-
inﬂammatory drug [23], and a classical opioid agonist,
respectively, would also reverse the detected increase in
MPO activity. Indeed, our data conﬁrmed and expanded
previous works from our and other laboratories [12, 24],
showing that celecoxib signiﬁcantly reduced the number of
blood neutrophils, which paralleled the reduction of cells
present in inﬂamed gingival tissues [12], thus conﬁrming
in this model its activity as an anti-inﬂammatory drug.
Moreover,thedecreaseinMPOcontentalongwithareduced
number in tissue cells by celecoxib suggests a more selective
anti-inﬂammatory eﬀect in this model than that shown by
morphine, as discussed below.
In fact, it was intriguing to observe a reduction in the
MPO levels also in rats treated with morphine, since it was
previously shown that the opioid agonist was unable to
aﬀect the increased cell number in ligated sites, although
it decreased other indicators of periodontal disease like
bone and attachment loss, as shown here and in [11]. As
for celecoxib, morphine demonstrated to have a qualitative
eﬀect on blood leukocytes since it decreased the number
of neutrophils rather than aﬀecting other leukocyte species.
Since neutrophils were the predominant leukocyte in cir-
culating cells, and neutrophils are considered to be key
cells in periodontal destruction [22], the beneﬁcial eﬀect
of morphine seen in compromised periodontal tissues was
attributed to its property to reduce blood (circulating)
neutrophils present in tissues rather than aﬀecting the
newly emigrated local cells. Our data are in line with
other studies, which showed that morphine reduced both
the MPO activity and the number of neutrophils, usingMediators of Inﬂammation 5
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Figure 3: Leukocyte recruitment and myeloperoxidase activity in gingivomucosal tissue surrounding rat molar tooth from naive, nontreated and
periodontal-diseased treated rats. Either celecoxib (12mg/kg/day) or morphine (1mg/kg/day) was administered subcutaneously (0.1mL per
100gbodyweight)onceaday,for3consecutivedays,from3rdto5thdayafterligation.Animalswerekilledonthe11thdayofligation.Sterile
physiological saline was given in the same volume and route of administration in control animals. Naive (N) animals were left nonligated.
Gingivomucosal tissue samples of ligated (ipsilateral) and non-ligated (contralateral) second molar tooth (∼20mm2)w e r er e m o v e df r o m
naive, and drug-treated rats and were prepared for histological analysis (Panels (a) and (b)) and MPO activity (Panels (c) and (d)) as
described in Materials and Methods. In panels (a) and (b) ∗indicates a signiﬁcant diﬀerence (P< .05) from contralateral side and in panels
(c) and (d) ∗and # indicate signiﬁcant diﬀerence (P< .05) in relation to naive and control group, respectively; using one-way ANOVA
followed by Student-Newman-Keuls test; 4–6 animals per group.
an immunohistochemistry technique [25]. They also suggest
that local neutrophils derived from a chronic inﬂammation
are functionally distinct from circulating neutrophils, as the
local cell numbers were not modiﬁed by systemic morphine
treatment. A possible explanation for such ﬁndings would
be, for instance, that the local activated neutrophils loose
their opioid sensitive receptors, or alternatively, change the
nature of their expressed opioid receptors. Notwithstanding,
these possibilities were not further addressed in the present
study. Taken together, our data clearly demonstrated that6 Mediators of Inﬂammation
(1)bloodneutrophilnumber,(2)localtotalcellnumber,and
(3) MPO activity allow the detection of a diﬀerential proﬁle
of beneﬁcial eﬀects seen between celecoxib and morphine in
this model of chronic inﬂammation. Therefore, we propose
that this triad would be suitable to detect useful newer anti-
inﬂammatory drugs in periodontal disease.
In conclusion, our ﬁndings conﬁrm the association
between a high content of MPO and the presence of inﬂam-
mation in tissues. Notwithstanding, they also indicate that,
being done in a chronic condition, where the extravascular
content cannot be strictly deﬁned, MPO content reﬂects
more the existence of a systemic inﬂammation, rather than
a local inﬂammatory condition.
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